Regeneron (REGN) – General News
-
Starbucks, DoorDash, Roku, Qualcomm rise premarket; Peloton, Moderna fall
-
US FDA approves Regeneron's ultra-rare blood disease drug
-
First Republic, Deutsche Bank, Chevon, Block fall premarket; Regeneron rises
-
U.S. stocks are rising on hopes the Fed is headed for a pause
-
US FDA expands use of Regeneron's cholesterol drug in young children
-
Regeneron profit beats estimates on Dupixent strength
-
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.34%
-
Fed Drives Dollar Higher, BoE Hike, China Rally Stalls - What's Moving Markets
-
Regeneron's COVID-19 antibody drug may be less effective against Omicron
-
Regeneron's antibody drug shows protection against COVID-19 for up to 8 months
-
EU regulator advises use of Regeneron antibody cocktail for COVID-19
-
CDC says COVID variants could reduce the efficacy of monoclonal antibodies, but unlikely to have a large impact on vaccine immunity - Bloomberg
-
Regeneron says Roche successfully tested manufacture of COVID-19 drug used on Trump
-
U.S. strikes deal with Lilly for potential COVID-19 antibody drug
-
Eli Lilly strikes optimistic tone on COVID-19 therapy after trial failure
-
Exclusive: FDA faults quality control at Lilly plant making Trump-touted COVID drug
-
U.S. pauses Eli Lilly trial of antibody drug Trump touted as COVID-19 'cure' over safety concern
-
Fauci says 'reasonably good chance' Regeneron antibody therapy helped Trump
-
Wall Street gains as Trump to leave hospital, investors hope for stimulus
-
Regeneron says its COVID-19 treatment reduces viral levels, improves symptoms
-
AstraZeneca starts trial of COVID-19 antibody treatment
-
Roche, Regeneron link up to develop COVID-19 antibody cocktail
-
Teva Pharm second-quarter profit tops forecast, reaffirms 2020 outlook
-
Eli Lilly tests antibody drug to halt COVID-19 spread in U.S. nursing homes
-
Sanofi clinches $2 billion vaccines deal with Translate Bio
-
U.S. companies issue shares at fastest rate ever, selling the rally
-
Drugmaker Sanofi to raise over $11 billion via sale of Regeneron shares
-
Sanofi shares down despite $13 billion Regeneron payday
-
Investors await data on coronavirus drugs as market rally builds
-
Trump says he slashed red tape for vaccines, therapies
-
Wall Street jumps after Monday's historic sell-off as Fed boosts liquidity to fight coronavirus effect
-
Drugmaker Sanofi expects further profit growth from narrowed focus
-
Novartis takes on Sanofi, Amgen with $9.7 billion takeover of heart drug maker
-
Sanofi and Regeneron cut list price of cholesterol drug by 60 percent
-
Express Scripts targets Amgen, Lilly migraine drugs in pricing shift
-
Sanofi pegs U.S. drug price rises to below healthcare inflation
-
UPDATE: Alexion (ALXN) Peers Ramp
-
Pre-Open Movers 11/29: Regeneron (REGN) Soars On sanofi Deal, E*TRADE (ETFC) Up on $2.5B Cash Infusion
-
Largest $ Movers of Note - StreetInsider.com - 06/04/2007
-
StreetInsider.com Unusual 11 Mid-Day Movers 03/27/2007
-
StreetInsider.com Pre-Open Movers 10/19
-
Noteworthy Upgrades/Downgrades/New Coverage 04/24
Back to REGN Stock Lookup